A Phase 1, Open-Label, Multicenter Study to Determine the Pharmacokinetics and Safety of Intravenous Eravacycline in Children with Suspected or Confirmed Bacterial Infection
Clinical Trial Grant
Administered By
Pediatrics, Infectious Diseases
Awarded By
Tetraphase Pharmaceuticals, Inc.
Start Date
March 8, 2019
End Date
April 30, 2021
Administered By
Pediatrics, Infectious Diseases
Awarded By
Tetraphase Pharmaceuticals, Inc.
Start Date
March 8, 2019
End Date
April 30, 2021